EUVIMEDEUVIMED entdecken
Crossref

Post-marketing safety concerns with montelukast: A pharmacovigilance study based on the FDA adverse event reporting system

Zhimin Ou, Ying Han, Wei Zhuang, Yunshan Xiao, Shuying Cai, Xueqin Zhang

Int. Journal of Clinical Pharmacology and Therapeutics · 2024

DOI: 10.5414/cp204560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2024. Verfasst von Zhimin Ou und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acetates, Cyclopropanes, Quinolines, Pharmacovigilance. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetatesCyclopropanesQuinolinesPharmacovigilanceAdverse Drug Reaction Reporting SystemsSulfidesUnited States Food and Drug AdministrationHumansUnited StatesAdultFemaleMaleAdolescentMiddle AgedYoung AdultChildProduct Surveillance, PostmarketingAgedMental DisordersChild, PreschoolDatabases, FactualAnti-Asthmatic AgentsAge Factors

Substanzen

montelukastAcetatesCyclopropanesQuinolinesSulfidesAnti-Asthmatic Agents

Zitieren

APA

Ou, Z., Han, Y., Zhuang, W., Xiao, Y., Cai, S., & Zhang, X. (2024). Post-marketing safety concerns with montelukast: A pharmacovigilance study based on the FDA adverse event reporting system. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204560

Vancouver

Ou Z, Han Y, Zhuang W, Xiao Y, Cai S, Zhang X. Post-marketing safety concerns with montelukast: A pharmacovigilance study based on the FDA adverse event reporting system. Int. Journal of Clinical Pharmacology and Therapeutics. 2024. doi:10.5414/cp204560

BibTeX
@article{Ou2024,
  author = {Ou, Zhimin and Han, Ying and Zhuang, Wei and Xiao, Yunshan and Cai, Shuying and Zhang, Xueqin},
  title = {Post-marketing safety concerns with montelukast: A pharmacovigilance study based on the FDA adverse event reporting system},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.5414/cp204560}
}
Kostenlos starten →